The @jimboonya.bsky.social lab at Fred Hutch found the use of sirolimus #GVHD prophylaxis in allo HCT recipients was linked to a higher risk for RSV infection, whereas higher serum neutralizing antibody levels were linked to a lower risk in the first 100 days post-transplant. https://wb.md/3Zokzua
RSV Antibody Levels Tied to Posttransplant Infection Risk
After hematopoietic cell transplant, sirolimus use for GVHD prophylaxis is linked to a higher RSV risk, whereas higher serum neutralizing antibody levels are tied to a lower risk within 100 days.
wb.md
